Skip to main content
Signal8

MOOS WALTER H

SEC insider (Form 3/4/5 filer). CIK 0001190272. Director at RIGEL PHARMACEUTICALS INC (RIGL). 4 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies MOOS WALTER H has filed insider reports for

  • RIGEL PHARMACEUTICALS INC (RIGL): Director
MOOS WALTER H profile photo

MOOS WALTER H

CIK: 0001190272

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RIGEL PHARMACEUTICALS INC logo
RIGL

RIGEL PHARMACEUTICALS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    May 15, 2026
    Award
    Direct
    5.8K shares-
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Feb 20, 2026
    Exercise
    Direct
    4K shares at avg. $24.00$96K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    Feb 20, 2026
    Sale
    Direct
    4K shares at avg. $36.36$145K
  • RIGEL PHARMACEUTICALS INC logo
    RIGL

    RIGEL PHARMACEUTICALS INC

    May 23, 2025
    Award
    Direct
    2.5K shares-

1-4 of 4